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Abstract: The synthesis and evaluation 
of new dopamine based catechol 
anchors coupled to poly(ethylene 
glycol) (PEG) for surface modification 
of TiO2 surfaces is reported. Dopamine 
is modified by dimethylamine–
methylene (7) or trimethylammonium–
methylene (8) groups, and the 
preparation of mPEG-Glu didopamine 
polymer 11 is presented. All these PEG 
polymers allow for the generation of 
stable adlayers on TiO2 through mild 
dip-and-rinse procedures, as evaluated 
both by variable-angle spectroscopic 
ellipsometry (VASE) and X-Ray 
photoelectron spectroscopy. The 
resulting surfaces substantially reduced 
protein adsorption upon exposure to 
full human serum. 
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Introduction 
The non-specific attachment of macromolecules of biological nature 
such as proteins or of microorganisms such as bacteria or fungi to 
surfaces (so-called biofouling) is a fundamental problem in areas 
ranging from medical devices and biosensors[1] to protein production, 
handling and storage.[2] Surfaces suffer from biofouling as soon as 
they are exposed to biological fluids or protein solutions. This 
process[3] is often considered the first step related to nosocomial 
infections,[4] a serious problem nowadays in hospital settings. 
The direct approach to preventing such biofouling is the 
generation of antifouling surfaces,[5] i.e. coatings that repel the 
adhesion of proteins and cells. Over the last years, effective 
antifouling polymers have been developed including poly ethylene 
glycol[6] polyglycerol,[7] poly(ethyleneoxide)-poly(propylene-
oxide)/pluronics,[8,9] peptoids,[10] poly-2-methyl-2-oxazoline[11] and 
others. The remaining general challenge consists in attaching these 
polymers to surfaces in a mild, rapid and efficient way. Several 
approaches have been developed based on poly-electrolytes,[12] 
silanes[13] or thiols[14] on gold. All these approaches suffer from 
limitations regarding scope, stability or reactivity of anchoring 
groups. Recently, catechols have been presented as promising 
alternative adhesives in surface modifications.[15] These anchors are 
found in mussel-adhesive proteins (MAPs),[16] which are responsible 
for the very strong wet adhesion of mussels to surfaces. MAPs have 
been shown to contain up to 27% of the catechol 
dihydroxyphenylalanine (1, DOPA), which is the key constituent for 
adhesion. Based on early work by Waite and coworkers,[15a] and 
then Grätzel and coworkers,[15b] Messersmith and coworkers[15c-h] 
demonstrated the usefulness of catechols for surface 
functionalization. In these systems, however, oligomers of DOPA 
such as 2 are required to achieve sufficient adhesion stability and 
protein resistance. We were able to overcome this limitation by 
introducing the anchor 3[17a] for effective single site attachment 
based on the iron chelator anachelin.[18] This biomimetic 
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strategy allowed for the generation of PEG-based, protein-
resistant[17a] and cell-resistant[17b] surfaces, with the drawback that 
the anchor requires multi-step organic synthesis involving heavy 
metal-based[18a-b] or enzymatic[18c-d] conversions. We sought to 
structurally simplify this anchor, and, while retaining its benefits, 
making its preparation more straightforward. In this article, we 
present structurally simple, easy-to-produce anchors that allow for 
the generation of protein-resistant TiO2 surfaces through 
straightforward dip-and-rinse procedures. 
Results and Discussion 
The goal of this investigation was the design of an effective catechol 
surface anchor that can generate protein-resistant surfaces, and that 
is readily available via a short synthetic route. We initially proposed 
that the key to successful surface immobilization via single site 
attachment is the combination of both catechol and a positive 
ammonium group as in 3.[17a] These functional units should 
synergistically act on surface binding – with the catechol as the 
anchoring group in a similar fashion to MAPs, and the positive 
charge inducing favorable interactions with the negatively charged 
surface of the metal oxide. Therefore, we turned our attention to 
compound 4, which is readily available from Boc-L-DOPA.[18a,b] 
This mono-protected catechol diamine exists at physiological 
conditions in a charged state thus displaying the desired properties 
of catechol and positive charge. A permanent, pH-independent 
positive charge was introduced by N-methylation of 4 in one step 
with excellent yield (97 %) (Scheme 1). The resulting compound 5 
can therefore be obtained through a short synthetic sequence from 
DOPA. In addition to the mono catechol anchors such as 4 and 5, 
we were interested in dicatechol anchors because of their increased 
adhesion stability on surfaces.[15g] Thus, the dicatechol-diamine 6 
was prepared in two steps from 4, simply via deprotection of 4 and 
coupling to Boc-L-DOPA. The three anchors 4-6 were deprotected, 
and coupled to poly(ethylene glycol) (PEG-5000) via the 
corresponding PEG-succinidyl esters and purified by size exclusion 
chromatography. The resulting polymers 7-9 were thus readily 
available for surface functionalization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Preparation of catechol-PEG conjugates for surface modification: a) Boc2O, 
NaOH (aq.), dioxane, RT, 16h; b) i.  i-BuOCOCl, THF, -35°C, 0.5h; ii. HNMe2, THF, -
35°C to RT, 16h, 68% (over 3 steps); c) Cs2CO3, BnBr, acetone, reflux, 4h, 83%; d) i. 
TFA, CH2Cl2, 0°C, 1h; ii. BH3•THF, THF, 0°C to RT, 16h; iii. Boc2O, NaOH (aq.), 
dioxane, RT, 16h, 53% (over 3 steps); e) H2, Pd/C, AcOH, MeOH, 14h, RT, 99%; f) 
CH3I, CH2Cl2/MeOH (2:1), 6h, RT; g) TFA, CH2Cl2, 0°C, 1h; h) Boc-L-DOPA, NEt3, 
HOBt, EDC, 14h, RT, 54% (over 2 steps); i) HCl (4M) in dioxane, dioxane, 0°C, 2h; j) 
mPEG-SPA, NMM, CH2Cl2/DMF (1:1), RT, 64% (for 7), 44 % (for 8), 60 % (for 9). 
 
In addition, we prepared the didopamine polymer 11 in three 
steps from Boc-L-Glu (10), via coupling to dopamine, deprotection 
and pegylation with mPEG succinidyl ester (Scheme 2). This 
compound 11 was designed in view of beneficial properties through 
bidentate anchoring of the catechols on the surface, while being 
readily available through a short 3 step synthetic sequence. From a 
mechanisitc point of view, this compound could also allow for the 
investigation of the role of the amino group in 9 with respect to two 
catechol units. Compound 11 should also display increased binding 
properties, when compared to dopamine PEG polymer 12, as noted 
earlier for DOPA based polymers.[10, 15g] 
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Scheme 2. Preparation of mPEG didopamine polymer 11: a) Dopamine hydrochloride, 
NEt3, HOBt, EDC, 14h, RT, CHCl3; b) HCl (4M) in dioxane, dioxane, 0°C, 2h; c) 
mPEG-SPA, NMM, CH2Cl2/DMF (1:1), RT, 58%. 
The generation of protein-resistant surfaces was then carried 
out by means of spontaneous adsorption (self assembly) using a dip-
and-rinse protocol. As surface, TiO2 was chosen in view of its 
relevance for the field of biomedical implants and biosensors.[19] 
Thus, clean TiO2 surfaces were dipped in dilute solutions of 7-9 and 
11-12 (0.1 mg ml-1 of polymers in high salt buffer (0.1 M MOPS/0.6 
M NaCl/0.6 M K2SO4)) for 4 h at 50 ºC. These ‘cloud point’ 
conditions were chosen to achieve dense packing of PEG and thus 
maximize PEG surface density.[5a] After incubation, the resulting 
surfaces were shortly rinsed with water, and the thickness of the 
adlayer was measured by variable angle spectroscopic ellipsometry 
(VASE). This measured thickness is proportional to the amount of 
polymer adsorbed and thus directly reflects the mass of PEG on the 
surface. From these values (Figure 1, circles), it is evident that 
polymer 8 featuring the quaternary ammonium anchor as well as the 
didopamine polymer 11 displayed the highest mass adsorbed. 
Among the monocatechol polymers, the performance of 8 is 
comparable to the anachelin chromophore polymer 3 and to the one 
measured for dopamine derived 12. Clearly, the non-permanently 
charged polymer 7 displayed a lower adlayer thickness. As a next 
step, the polymers were equilibrated by exposing the surfaces to 
physiological buffer (HEPES 2; pH 7.4) for 24 h. At the same time, 
the PEG chains become rehydrated in this process. Adlayer 
thickness of all polymers was again measured by VASE (Figure 1, 
squares). The quaternary ammonium polymer 8 again displayed a 
high value, with a measured thickness of roughly 17 Å. This is 
comparable to control polymer 3, and to dopamine derived 12.  The 
tertiary amine polymer 7 showed a significantly lower thickness, 
with a measured value of 9.8 Å.  
 
Figure 1. Adlayer  thickness of polymers 3 (8), 7 (10), 8 (9), 9 (10), 11 (6) and 12 (8) as 
measured by VASE (numbers in parentheses refer to number of independent 
experiments, error bars denote the standard deviation). Filled circless correspond to the 
values measured directly after adsorption in cloud point buffer, empty squares 
correspond to values measured after equilibration in physiological buffer at pH 7.4. 
We next investigated the adlayer thickness of divalent 
didopamine derivatives 9 and 11 (Figure 1). Interestingly, the 
derivative 9 featuring additional amino groups displayed similar low 
initial adlayer thickness when compared to the parent monovalent 
polymer 7, and, after 24 h exposure to buffer, adlayer thickness of 
8.8 Å was determined. The divalent dopamine derivative 11, 
however, gave the highest adlayer thickness, both after adsorption 
(ca. 25 Å) and after 24 h incubation in buffer (ca. 18 Å). 
From these data, the following conclusions can be drawn: (1) A 
permanent positive charge, present for example in 8, results in 
higher values for the adlayer thickness (on negatively charged 
surfaces), and therefore higher adsorbed mass for the monovalent 
compounds. Thus, polymers such as 8 and the control 3 have 
superior adsorption properties when compared to non-permanently 
charged aminodopamines such as 7. (2) The didopamine polymer 11 
resulted in the highest adlayer thickness as determined by VASE. 
Clearly, an optimal arrangement of both catechols is beneficial for 
surface attachment. In contrast, the diamino dopamine polymer 9 
performed poorly, with layer thicknesses similar to its monovalent 
counterpart 7. Increased steric hindrance expected for molecule 9 
when compared to 11 is possibly the reason for the observed lower 
adlayer thickness. Molecular modelling supports this view, where 
the dimethylamino group in 9 appears to spatially separate the 
catechol units and thus preventing multivalent attachment (data not 
shown). From the adsorption data after incubation for 24 h under 
physiological conditions, it can be concluded that the performance 
regarding adlayer thickness of the group of polymers 3, 8, 11, and 
12 are superior to 7 and 9. 
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Figure 2. Measured increase in layer thickness due to serum 
adsorption on polymer adlayers of 3, 7, 8, 9, 11 and 12 plotted vs. 
polymer adlayer thickness after equilibration for 24h in 
physiological buffer. “Control” refers to the bare TiO2 surface. 
 
 Next, we investigated the protein adsorption to the TiO2 
surfaces coated with the different polymers as prepared above. The 
resulting surfaces were subsequently exposed to human serum for 
20 minutes, rinsed with buffer and ultra-pure water and the resulting 
increase in layer thickness was measured by VASE (Figure 2). 
These results demonstrate that coatings of 7 and 8 substantially 
reduce non-specific serum adsorption when compared to bare TiO2 
(Figure 2, control).  The measured protein resistance values for 7 
and 8 are slightly lower when compared to the anachelin 
chromophore 3, reflecting their lower polymer adlayer thicknesses 
(Figure 1). In addition, while the introduction of a permanent charge 
such as in 8 leads to increased PEG surface coverage as judged by 
VASE (Figure 1), it has no influence on the protein resistance 
(Figure 2), as both polymers 7 and 8 are equally efficient towards 
this goal. 
 Surprisingly, the diamino catechol polymer 9 coating was 
inefficient in reducing protein-adsorbed mass (Figure 2), in contrast 
to the expectation given the adlayer thickness of 10 Å after buffer 
incubation (Figure 1). The reason for this unexpected result is 
unclear at present. A significantly better performance in this respect 
showed didopamine polymer 11, with over 95 % reduction of 
protein adsorption when compared to the control. This polymer 11 
as well as the charged monovalent 8 thus display with regard to 
performance in adlayer thickness and protein resistance generally 
the best values. 
The data obtained from VASE experiments were further 
corroborated by X-ray photoelectron spectroscopy (XPS) 
measurements. For protein-resistant surfaces, the chemical 
composition of the adsorbate layer is expected to remain unchanged 
while surfaces that adsorb proteins should show a substantial 
increase in the surface nitrogen concentration as well as changes in 
the composition of the carbon components of the C1s signal. The 
XPS data confirmed that surfaces identified by VASE as protein 
resistant, e.g. 3, 11 and 12, also show the smallest change in their 
chemical composition (shown in supporting information). The 
combined XPS and VASE findings for these three polymers clearly 
demonstrate that the measured layer thickness after the serum test 
mostly reflects the polymer film and that adsorption or exchange of 
polymer molecules by proteins has not taken place to a significant 
degree. In contrast, the films obtained from 7 and 9 show a 
substantial increase in the nitrogen as well as carbon surface 
concentration. The XPS data also demonstrate, that thicker polymer 
layers (corresponding to a higher C/Ti atomic concentration ratio) 
with correspondingly higher PEG chain surface density result in 
more favorable protein resistance which is in agreement with the 
ellipsometry data (Figure 2).  
Conclusion 
In conclusion, we presented the synthesis and evaluation of a 
series of new dopamine based anchors for surface functionalization. 
Two anchors with excellent properties were identified: dopamine 8 
with a permanent positive charge displayed comparable adlayer 
thickness when compared to the reference 3. The didopamine 
polymer 11 was identified as the anchor of choice, as this compound 
showed the highest adlayer thickness while displaying a large 
reduction of protein attachment. In addition, the didopamine anchor 
of 11 can be prepared from Boc-L-Glu and dopamine in a 
straightforward and convenient one-step process. Benefits of the 
new anchors included in 8 and 11 are: (1) Ease of synthesis when 
compared to formerly reported systems such as 3, (2) operationally 
simple dip-and-rinse protocols for the generation of protein-resistant 
surfaces, and (3) mild surface functionalization through catechols, 
which are compatible with many functional groups. Applications of 
the novel surface-active molecules for the generation of functional 
surfaces are currently underway in our laboratories. 
 
Experimental Section 
Materials and Methods: Chemicals were purchased from Fluka, ABCR or Acros and 
used without further purification. Analytical thin layer chromatography (TLC) was 
performed on Merck silica gel 60 F254 plates (0.25 mm thickness) precoated with a 
fluorescent indicator. The developed plates were examined under UV light and stained 
with ceric ammonium molybdate followed by heating. All 1H and 13C NMR spectra 
were recorded using a Bruker DPX 400 MHz (1H) or 100 MHz (13C) FT spectrometer at 
RT, chemical shift ! given in ppm and coupling constant J in Hz. IR spectra were 
recorded using a Varian 800 FT-IR ATR Spectrometer. The absorptions are reported in 
cm-1 and the IR bands were assigned as s (strong), m (medium) or w (weak). All mass 
spectra were recorded by the Mass Spectroscopy service of EPF Lausanne on 
MICROMASS (ESI) Q-TOF Ultima API. Melting points were determined using a 
Büchi B-545 apparatus in open capillaries and are uncorrected. Compound 4 was 
prepared according to the literature,[18] and procedures and data are reported in the 
supporting information. 
TiO2 Surfaces and surface preparation: Silicon wafers (Si-Mat Silicon Materials 
Landsberg/ Deutschland) were coated with TiO2 (15/20 nm) by magnetron sputtering 
(PSI Villingen, Switzerland). Metal oxide coated wafers were subsequently sawn into 
1cm x 1cm pieces. Prior to polymer modification, TiO2-coated silicon wafers were 
sonicated in toluene twice for 10 min followed by two times 7 minutes sonication 
in 2-propanol and dried under a stream of nitrogen and finally exposed to O2 plasma 
(Harrick Scientific Corporation, Ossining, NY) for 3 min to remove adventitious 
contamination from the surface. 
Ellipsometry (VASE): The adlayer thickness on TiO2 wafers was measured by 
M-2000FTM Variable angle spectroscopic ellipsometry (J. A. Woollam Co., Inc.) 
at 65°C, 70°C and 75°C using wavelengths from 370 to 1000 nm. VASE spectra were 
fit with multilayer modes using a custom analysis software (WVASE 32). 
X-ray Photoelectron Spectroscopy (XPS): XPS data were acquired on a SIGMA 
probe thermo XPS system spectrophotometer. The instrument was equipped with 
a multichannel detector and an Alpha 110 hemispherical analyzer. All spectra were 
acquired at 300 W with an Al K! X-ray source (1486.6 eV) with large area spotsize. 
High-resolution spectra (C 1s, N 1s) were recorded with 0.1 eV step size and 
25 eV pass energy. Recorded spectra were referenced to the aliphatic hydrocarbon C1s 
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signal at 285.0 eV. Data were analyzed using the program CasaXPS [Version 2.3.5 
www.casaxps.com]. The signals were fitted using Gaussian-Lorentzian functions and 
Marquardt-Levenberg optimization algorithm following Shirley iterative background 
subtraction. 
Preparation of trimethylammonium dopamine 5: Compound 4 (44 mg, 0.14 mmol, 
1.0 eq) was dissolved in CH2Cl2/MeOH (2/1) (1 mL). MeI (44 µL, 0.71 mmol, 5.0 eq.) 
was added and the solution stirred at RT for 6 hours under N2. The solvent was removed 
under reduced pressure to give 62 mg (0.14 mmol, 97%) of the title compound 5. 1H-
NMR (CD3OD, 400 Mhz) 1.36-1.39 (s, 9H, Boc-rotamers), 2.61-2.74 (m, 2H) 3.17 (s, 
9H), 3.49 (m, 2H), 4.20-4.23 (m, 1H), 6.59-6.61 (m, 1H), 6.72-6.74 (m, 2H); 13C-NMR 
(CD3OD, 100 MHz) 27.5, 27.6 (Boc rotamers), 40.7, 48.4, 54.8, 73.8, 79.5, 115.6, 116.8, 
123.2, 132.0, 144.6, 145.8, 155.6; HRMS calcd for C17H29N2O4 [M+H]
+: 325.2122; 
found 325.2127. 
Preparation of compound 6: Compound 4 (250 mg, 0.81 mmol, 1.0 eq.) was 
suspended in CH2Cl2 (4 ml), cooled to 0ºC under N2. TFA (2 mL) was added dropwise 
and the solution stirred at 0ºC for 1 hour and at RT for 1 hour. The reaction mixture was 
then concentrated, redissolved in toluene (1 mL), concentrated and dried under high 
pressure. The residue was dissolved in CH2Cl2 (10 mL), Et3N (450 µL, 4.0 eq.) and 
HOBt (130 mg, 1.2 eq.) were added and the solution stirred for 5 minutes at RT. 
EDC•HCl (165 mg, 1.2 eq.) and a solution of BOC-L-DOPA (259 mg, 1.1 eq.) in 
CH2Cl2 (3 mL) were added. The solution was stirred at 0ºC for 1 hour and at RT for 18 
hours under N2 under the exclusion of light. The reaction mixture was concentrated, 
diluted in Et2O and washed with 1M HCl (2 x 10 mL), saturated NaHCO3 (2 x 10 mL) 
and brine (10 mL). The organic layer was dried (MgSO4), concentrated and the residue 
purified by chromatography on SiO2 (CH2Cl2/MeOH (8:1)) to give 287 mg (0.63 mmol, 
54%) of the title compound. 
Preparation of mPEG-SPA: mPEG-propionic acid (150 mg, 30 µmol, 1.0 eq.) was 
dissolved in CHCl3 (3 mL) at 0ºC under N2. DCC (7 mg, 33 µmol, 1.1 eq.) was added 
and the solution stirred for 15 minutes at 0ºC. NHS (4 mg, 33 µmol, 1.1 eq.) was added 
and the solution stirred for 1 hour at 0ºC and for 14 hours at RT under N2. The reaction 
mixture was kept at 4ºC for 4 hours and filtered. The solvent was removed and the 
residue was dissolved in Et2O (30 mL) and stored at 4ºC for 1 hour. Filtration gave 146 
mg (29 µmol, 97%) of the title compound, which was used without further purification. 
Preparation of polymer 7: Compound 4 (14 mg, 30 µmol, 3.0 eq.) was dissolved in 
CH2Cl2 (1 mL), cooled at 0ºC under N2, and TFA (1 mL) was added dropwise. The 
solution stirred for 1 hour at 0ºC and for 1 hour at RT. The solvent was removed and the 
residue was dissolved in toluene and concentrated. The residue was dissolved in 
CH2Cl2/DMF (1/1) (1 mL) under N2. N-methylmorpholine (50 µL) was added dropwise 
and the solution stirred at RT for 15 minutes. mPEG-SPA (50 mg, 10 µmol, 1.0 eq.) was 
added an the solution stirred for 14 hours at RT under N2. The solution was filtrated, 
diluted in Et2O (30 mL) and stored at 4ºC for 4 hours. Filtration and purification by 
chromatography on Sephadex LH-20 (MeOH) gave 22 mg (4 µmol, 44%) of the title 
compound. 
Preparation of polymer 8: Compound 5 (9 mg, 30 µmol, 3.0 eq.) was dissolved in 
CH2Cl2 (1 mL), cooled at 0ºC under N2, and TFA (1 mL) was added dropwise. The 
solution stirred for 1 hour at 0ºC and for 1 hour at RT. The solvent was removed and the 
residue was dissolved in toluene and concentrated. The residue was dissolved in 
CH2Cl2/DMF (1/1) (1 mL) under N2. N-methylmorpholine (50 µL) was added dropwise 
and the solution stirred at RT for 15 minutes. mPEG-SPA (50 mg, 10 µmol, 1.0 eq.) was 
added an the solution stirred for 14 hours at RT under N2. The solution was filtrated, 
diluted in Et2O (30 mL) and stored at 4ºC for 4 hours. Filtration and purification by 
chromatography on Sephadex LH-20 (MeOH) gave 32 mg (6 µmol, 64%) of the title 
compound. 
Preparation of polymer 9: Compound 6 (15 mg, 30 µmol, 3.0 eq.) was dissolved in 
CH2Cl2 (1 mL), cooled at 0ºC under N2, and TFA (1 mL) was added dropwise. The 
solution stirred for 1 hour at 0ºC and for 1 hour at RT. The solvent was removed and the 
residue was dissolved in toluene and concentrated. The residue was dissolved in 
CH2Cl2/DMF (1/1) (1 mL) under N2. N-methylmorpholine (50 µL) was added dropwise 
and the solution stirred at RT for 15 minutes. mPEG-SPA (50 mg, 10 µmol, 1.0 eq.) was 
added an the solution stirred for 14 hours at RT under N2. The solution was filtrated, 
diluted in Et2O (30 mL) and storred at 4ºC for 4 hours. Filtration and purification by 
chromatography on Sephadex LH-20 (MeOH) gave 30 mg (5 µmol, 60%) of the title 
compound. 
Preparation of polymer 11: Boc-L-Glu (10) (300 mg, 1.2 mmol, 1.0 eq) was dissolved 
in CHCl3 (3 mL) and cooled to 0°C (ice-bath). NEt3 (750 "L, 5.3 mmol, 4.0 eq), HOBt 
(360 mg, 2.4 mmol, 2.00 eq), EDC hydrochloride (510 mg, 2.7 mmol, 2.2 eq) and 
dopamine hydrochloride (690 mg, 3.6 mmol, 3.00 eq) were sequentially added. The 
reaction mixture stirred at 0°C for 1 hour and at RT for 16 h. The mixture was diluted 
with CHCl3 (10 mL), washed with 1N HCl (2 x 10 mL), sat. NaHCO3 (2 x 10 mL) and 
brine (10 mL). The organic layer was dried over Na2SO4, filtered and concentrated. The 
residue was purified by chromatography on SiO2 (CH2Cl2/MeOH 9/1) to give 477 mg 
(0.92 mmol, 76%) of (S)-tert-butyl 1,5-bis(3,4-dihydroxyphenethylamino)-1,5-
dioxopentan-2-ylcarbamate. 1H-NMR (400 MHz, CDCl3) 1.41-1.44 (s, 9H, Boc 
rotamers), 1.68 (m, 2H), 1.82 (m, 2H), 2.03 (m, 2H), 2.30 (m, 2H), 2.66 (m, 2H), 4.20 
(m, 1H), 6.56-6.61 (m, 2H), 6.63 (d, J = 0.96 Hz, 2H), 6.79 (d, J = 8.32 Hz, 2H). 13C-
NMR (CDCl3, 100 MHz) 27.2, 28.2, 29.6, 34.6, 34.8, 40.4, 41.1, 51.8, 80.4, 115.3, 
115.5, 115.7, 115.8, 120.5, 120.6, 130.5, 130.7, 143.0, 143.1, 144.0, 144.1, 155.9, 171.9, 
173.9  IR 3402m, 3010m, 1780s, 1580s, 1273s, 1151s. (S)-tert-butyl 1,5-bis(3,4-
dihydroxyphenethylamino)-1,5-dioxopentan-2-ylcarbamate (15 mg, 30 "mol, 3.0 eq.) 
was dissolved in CH2Cl2 (1 mL), cooled at 0ºC under N2, and CF3CO2H (1 mL) was 
added dropwise. The solution stirred for 1 hour at 0ºC and for 1 hour at RT. The solvent 
was removed and the residue was dissolved in toluene and concentrated. The residue 
was dissolved in CH2Cl2/DMF (1/1) (1 mL) under N2. N-methylmorpholine (50 "L) was 
added dropwise and the solution stirred at RT for 15 minutes. mPEG-SPA (50 mg, 10 
"mol, 1.0 eq.) was added an the solution stirred for 14 hours at RT under N2. The 
solution was filtrated, diluted in Et2O (30 mL) and stored at 4ºC for 4 hours. Filtration 
and purification by chromatography on Sephadex LH-20 (MeOH) gave 30 mg (5 "mol, 
56%) of the title compound 11. 
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Protein-resistant surfaces can be 
generated though mild dip-and-rinse 
functionalization of TiO2 surfaces 
with dopamine derived PEG polymers. 
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